Aerie Pharmaceuticals (AERI)
$21.44 0.00 (0.00%)
16:47 EST AERI Stock Quote Delayed 15 Minutes
Previous Close $21.44
Market Cap 846.81M
PE Ratio -4.87
Volume (Avg. Vol.) 550,600
Day's Range 20.93 - 21.78
52-Week Range 17.15 - 50.10
Dividend & Yield N/A (N/A)
AERI Stock Predictions, Articles, and Aerie Pharmaceuticals News
- From InvestorPlace
- From the Web
For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.
These 10 monster growth stocks to buy all offer exciting opportunities. There's the important information for investors to keep in mind.
With the new year looming, now is the time for a quick portfolio refresh. We've pinpointed 10 stocks to buy with a 'Strong Buy' rating from the Street that are primed to outperform the market in 2018.
Despite a fairly upbeat performance of the pharma and biotech sector, caution has to be exercised before choosing a stock for investment as a few drug companies....
10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
The following stocks were moving the Manufacturing sector today.
3 Stocks to Watch Thursday: Viacom, Inc. (VIAB), Aerie Pharmaceuticals Inc (AERI) and Bluebird Bio Inc (BLUE)
Aerie Pharmaceuticals (AERI) and Bluebird Bio (BLUE) should open Thursday strongly higher, while Viacom (VIAB) is trending up against a few headwinds
Yesterday it was reported that the CSO of Aerie Pharma (AERI – Research Report), Casey Kopczynski, exercised options to buy 117,000 AERI shares at $0.40 a share, for a total transaction value of $46.8K. The options were close to expired and Casey Kopczynski retained stocks. This recent transaction increases Casey Kopczynski’s holding in the company
From Seeking Alpha
Monday’s Midday Stock Update: Karyopharm Therapeutics (KPTI), Peabody Energy Comm (BTU), Arrowhead Research (ARWR), Blueprint Medicines (BPMC), Aerie Pharma (AERI)
So far Monday, December 2, NASDAQ is down -4.72% and the S&P is down -2.6%. Here are this morning’s most active stocks: Karyopharm Therapeutics (KPTI – Research Report), Peabody Energy Comm (BTU – Research Report), Arrowhead Research (ARWR – Research Report), Blueprint Medicines (BPMC – Research Report) and Aerie Pharma (AERI – Research Report). Karyopharm
In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report), with a price target of $40.00. The company’s shares closed last Monday at $19.09, close to its 52-week low of $17.15. According to TipRanks.com, Belanger is a 3-star analyst with an average return of 1.2%
Navellier RatingsPowered by Portfolio Grader